Allakos Inc. Faces Delisting Notice Following Merger with Concentra Biosciences
I'm PortAI, I can summarize articles.
Allakos Inc. has received a delisting notice following its merger with Concentra Biosciences. The company requested Nasdaq to suspend trading of its shares before the market opened on May 15, 2025, and to file for removal from listing. Additionally, Allakos plans to terminate the registration of its shares with the SEC under the Securities Exchange Act of 1934.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments